Literature DB >> 16278496

Cardiovascular collapse from low dose bupivacaine.

Marc E Levsky1, Michael A Miller.   

Abstract

Bupivacaine is a long-acting local anesthetic agent that is very widely used for cutaneous infiltration, peripheral nerve blocks, epidural anesthesia, and spinal anesthesia. Well-described cardiotoxic effects of bupivacaine and other members of its class include dysrhythmias, hypotension, and depression of cardiac output. The minimum IV dose of bupivacaine previously associated with significant toxicity in humans is 1.6 mg/kg. A case is reported of bradyasystolic arrest with post resuscitation shock, without significant central nervous system (CNS) toxicity, following the injection of less than 1.1 mg/kg bupivacaine in an adult.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278496

Source DB:  PubMed          Journal:  Can J Clin Pharmacol        ISSN: 1198-581X


  6 in total

1.  Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

Authors:  Parisa Partownavid; Soban Umar; Jingyuan Li; Siamak Rahman; Mansoureh Eghbali
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

2.  Influence of bupivacaine injection dose rate on cardiovascular depression, subsequent hemodynamic course, and related bupivacaine plasma levels in piglets.

Authors:  Jacqueline Mauch; Annette P N Kutter; Olga Martin Jurado; Nelly Spielmann; Mital H Dave; Regula Bettschart-Wolfensberger; Markus Weiss
Journal:  J Anesth       Date:  2011-07-12       Impact factor: 2.078

3.  Epinephrine induces rapid deterioration in pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary pressure-dependent phenomenon.

Authors:  Vijay Krishnamoorthy; David B Hiller; Richard Ripper; Bocheng Lin; Stephen M Vogel; Douglas L Feinstein; Sarah Oswald; Leelach Rothschild; Priscilla Hensel; Israel Rubinstein; Richard Minshall; Guy L Weinberg
Journal:  Anesthesiology       Date:  2012-10       Impact factor: 7.892

4.  Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation.

Authors:  Louis E Samuels; Elena Casanova-Ghosh; Christopher Droogan
Journal:  J Cardiothorac Surg       Date:  2010-12-08       Impact factor: 1.637

5.  Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.

Authors:  Brigitte M Richard; Douglas E Rickert; Paul E Newton; Laura R Ott; Dean Haan; Abram N Brubaker; Phaedra I Cole; Paul E Ross; Marlon C Rebelatto; Keith G Nelson
Journal:  J Drug Deliv       Date:  2011-10-05

6.  Are reinfusion drains safe to use with periarticular liposomal bupivacaine? An analysis of systemic bupivacaine toxicity.

Authors:  Marc R Angerame; Gavin P Hart; Susan M Odum; Bryan D Springer
Journal:  Arthroplast Today       Date:  2017-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.